Hua Medicine (Shanghai) Ltd.

HK$2.21As of Sun 8 Nov 2026, 12:00 UTC
HKEX:2552Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 8Y CAGR (15.00%)
Div yield —
ROE (10.51%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.85
PE TTM —
TSR TTM (37.25%)
Mkt cap HK$2.212B
ROIC (4.96%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.71
22.33%
(63.75%)
Hold 1|9|4|11|8
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.03
0.03
0.03
0.03
7.50%
6.37%
16.93%
13.59%
Revenue¥M
103.5
100.4
105.7
106.6
0.97%
(1.03%)
5.33%
4.96%
Peers (US$282.2M)
Cap (US$)
PE
405.3M
15.40x
236.0M
6.126x
Capital
TTM
5Y
10Y
Leveragex
1.716
1.497
1.035
EBIT/Intx
1.205
0.728
0.647
Own earn%
(68.49)
(174.36)
(145.63)
Sh yield%
19.87
35.90
34.00
Owners
Insiders/Inst%
11.55
21.37
Short interest%
4.37
SBC / revenue%
5.58
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
19–25
$1 testx
0.0
Incr. ROIC%
8